Acemini action and efficacy

Asciminib (scemblix/asciminib) is a kinase inhibitor used to treat adult patients with the following:Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in the chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs) and T315Imutated chronic myelogenous leukemia Ph+chronic myelogenous leukemia.

Aceminibis a targeted therapy that works by specifically targeting the ABLmyristoyl pocket (STAMP ), a site of action that is different from other kinase inhibitors. This different way of working is important for people with Ph+ CML who have not responded adequately to other treatments or have troublesome side effects. It may also be used in patients with chronic myelogenous leukemia with the T315I mutation - Ph+ - a mutation that prevents certain tyrosine kinase inhibitors from working.

In a Phase 3 open-label study, patients who had previously received ≥2 timesTKIs< /span>TreatedCML-CPpatients were randomized (2:1) to receiveaceminib 40 mgtwice daily versus bosutinib500 mgonce daily. Randomization was stratified according to major cytogenetic response (MCyR) status at baseline. The primary objective was to compare major molecular response (MMR) rates at week 24 with aximinib and bosutinib. A total of 233 patients were randomly assigned to aceminib (n = 157) or bosutinib (n = 76). The median follow-up time was 14.9 months. No.The MMR rate at 24 weeks was 25.5% for Asiminib and 13.2% for Bosutinib. After adjusting for baselineMCyR, the difference in MMR rates between treatment groups was 12.2% span>(95%Confidence interval is2.19-22.30; two-sidedP =. 029). Compared with bosutinib, aximinib had fewer grade ≥3 adverse events (50.6% vs 60.5%) and fewer adverse events leading to treatment discontinuation (5.8% vs 21.1%). This study shows that aximinib is more effective than bosutinib and has a good safety profile. The retail price of Lucius Pharmaceuticals in Laos40mg60tablets4more than a thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.